Selective serotonin reuptake inhibitor use during pregnancy and major malformations the importance of serotonin for embryonic development and the effect of serotonin … Michael Levin Research Paper Summary

PRINT ENGLISH BIOELECTRICITY GUIDE

PRINT CHINESE BIOELECTRICITY GUIDE


What Was Observed? (Introduction)

  • SSRIs (Selective Serotonin Reuptake Inhibitors) are commonly used antidepressants that can cause serious birth defects when used during pregnancy.
  • Recent studies show that SSRIs increase the risk of malformations such as heart defects, craniosynostosis, and other major congenital malformations in babies.
  • SSRIs work by blocking the reuptake of serotonin, a neurotransmitter, which affects brain function and other body systems, including embryonic development.
  • The risk of these malformations outweighs the benefits of using SSRIs in pregnant women with mild to moderate depression.

What is Serotonin and Its Role in Embryonic Development?

  • Serotonin is a neurotransmitter that regulates mood, but it also plays a crucial role in development, especially in embryos.
  • It helps cells communicate and guides processes like organ development, body symmetry, and the positioning of vital organs like the heart and liver.
  • Embryos produce serotonin early on, even before the nervous system forms, and it is passed from the mother to the fetus through the placenta.
  • Serotonin signaling happens inside and outside cells, helping with cell division, shape, and movement during organ development.

How SSRIs Interfere with Serotonin During Pregnancy?

  • SSRIs block the transporter (SERT) that reabsorbs serotonin, which means more serotonin stays in the spaces between cells.
  • Blocking this process can disrupt how serotonin signals cells during the critical stages of development, leading to malformations.
  • SSRIs can also interfere with bioelectric signaling in cells, which plays a key role in forming organs and tissues.
  • These disruptions can cause problems with organ laterality (left-right asymmetry), heart formation, and other developmental processes.

Mechanisms of How SSRIs Cause Birth Defects

  • SSRIs can alter serotonin levels in the embryo, affecting how cells divide and form organs.
  • SSRIs also affect ion channels, which regulate electric signals in cells. These electric signals help organs develop correctly.
  • By disturbing calcium signaling, SSRIs can interfere with the cell movements needed to build a healthy body structure.

What Types of Malformations Are Caused by SSRIs?

  • SSRIs can cause major heart defects like ventricular septal defects, atrial septal defects, and transposition of the great arteries.
  • Other defects include craniosynostosis (early closure of skull sutures), gastrointestinal defects (like omphalocele and gastroschisis), and limb defects.
  • Disruptions in serotonin signaling also lead to problems in the development of organs like the brain, face, and heart.
  • There is also a higher risk of persistent pulmonary hypertension in newborns exposed to SSRIs during pregnancy.

When Are SSRIs Most Dangerous During Pregnancy?

  • SSRIs are most harmful when taken during the first trimester when key organ systems are forming.
  • Longer use of SSRIs during pregnancy increases the risk of malformations.
  • Higher doses of SSRIs also increase the risk of congenital defects.

The Role of Maternal Depression and Non-Pharmacological Treatments

  • While depression during pregnancy is common, there is no direct evidence linking maternal depression to birth defects.
  • Depressed mothers may have lifestyle factors (like smoking and poor nutrition) that increase the risk of malformations, but depression itself is not a risk factor for malformations.
  • Non-pharmacological treatments like exercise and psychotherapy are recommended as first-line treatments for depression during pregnancy.
  • SSRIs should only be used during pregnancy if absolutely necessary, and other treatments should be prioritized.

What Is the Risk of Using SSRIs for Treating Depression During Pregnancy?

  • The risk of serious birth defects outweighs the benefits of using SSRIs for mild to moderate depression during pregnancy.
  • SSRIs have been shown to be ineffective for treating severe or melancholic depression, which is rare during pregnancy.
  • Other treatments like psychotherapy and exercise have been proven to be effective and should be prioritized over medication.

Key Conclusions (Discussion)

  • SSRIs are teratogenic (cause birth defects) because they disrupt serotonin signaling, bioelectric signaling, and calcium signaling during embryonic development.
  • The malformations caused by SSRIs follow a consistent pattern, making it easier to link them to the drugs’ mechanism of action.
  • The benefits of SSRIs during pregnancy are outweighed by the risks of birth defects, and alternative treatments should be considered first.
  • More research is needed on the full extent of the effects of SSRIs on embryonic development.

SSRIs and Pregnancy: Risks vs. Benefits

  • The risks of major congenital malformations from SSRIs outweigh the benefits for most pregnant women, particularly those with mild to moderate depression.
  • Non-pharmacological treatments, including therapy and lifestyle changes, should be the first choice for treating depression during pregnancy.
  • SSRIs may be used only when absolutely necessary, and the risks to the fetus should be carefully considered before use.

观察到了什么? (引言)

  • SSRIs(选择性5-羟色胺再摄取抑制剂)是常用的抗抑郁药物,但在怀孕期间使用时可能导致严重的出生缺陷。
  • 最新研究表明,SSRIs增加了先天性心脏缺陷、颅缝早闭和其他重大先天性缺陷的风险。
  • SSRIs通过阻止5-羟色胺的再摄取来发挥作用,这会影响大脑功能和其他身体系统,包括胚胎发育。
  • 在怀孕期间,轻度到中度抑郁的孕妇使用SSRIs的风险大于药物的好处。

什么是5-羟色胺及其在胚胎发育中的作用?

  • 5-羟色胺不仅是神经递质,也在胚胎发育过程中发挥着重要作用,特别是在细胞之间的通讯。
  • 它帮助细胞沟通,并指导器官发育、身体对称性以及重要器官(如心脏和肝脏)的定位。
  • 胚胎在早期就开始产生5-羟色胺,甚至在神经系统形成之前,并通过胎盘将母体的5-羟色胺传递给胎儿。
  • 5-羟色胺在细胞内外的信号传递中发挥作用,帮助细胞分裂、形状变化和运动,从而支持器官的正常发育。

SSRIs如何在怀孕期间干扰5-羟色胺的作用?

  • SSRIs通过阻止转运蛋白(SERT)将5-羟色胺重新吸收,使得更多的5-羟色胺停留在细胞之间的空间。
  • 阻断这一过程会干扰5-羟色胺在胚胎发育关键阶段的信号传递,从而导致缺陷。
  • SSRIs还会干扰细胞的生物电信号,这些信号对器官的正常形成至关重要。
  • 这些干扰还可能导致器官的左右对称性(左-右轴)发生问题,从而影响心脏的发育等其他生理过程。

SSRIs如何引起出生缺陷的机制

  • SSRIs可以改变胚胎中5-羟色胺的水平,影响细胞的分裂和器官的形成。
  • SSRIs还会影响离子通道,这些通道在细胞内产生电信号,帮助器官的正常发育。
  • 通过扰乱钙信号传递,SSRIs可能会干扰细胞运动,从而影响正常的身体结构的构建。

SSRIs引起的缺陷类型

  • SSRIs可能导致严重的心脏缺陷,如室间隔缺损、房间隔缺损和大动脉转位。
  • 其他缺陷包括颅缝早闭(颅缝早期闭合)、胃肠道缺陷(如脐膺和肠膺)以及四肢缺陷。
  • 5-羟色胺信号的干扰还会导致大脑、面部和心脏等器官的发育问题。
  • SSRIs还增加了新生儿持久性肺动脉高压的风险。

怀孕期间使用SSRIs的关键时期

  • 怀孕的第一季度是最危险的时期,因为这一时期关键的器官系统正在形成。
  • 怀孕期间使用SSRIs时间越长,缺陷的风险越高。
  • 高剂量的SSRIs也增加了先天缺陷的风险。

母体抑郁症的作用及非药物治疗

  • 虽然孕期抑郁症很常见,但没有直接证据表明母体抑郁症会导致出生缺陷。
  • 抑郁的孕妇可能有一些生活习惯(如吸烟和营养不良)增加缺陷的风险,但抑郁症本身并不是缺陷的风险因素。
  • 建议通过运动和心理治疗等非药物治疗来优先治疗孕期抑郁症。
  • SSRIs应仅在绝对必要时使用,在此之前应优先考虑其他治疗。

治疗孕期抑郁症时SSRIs的风险与益处

  • 在孕期,SSRIs的风险大于轻度至中度抑郁孕妇使用药物的好处。
  • SSRIs在治疗严重或抑郁症时效果不佳,这在孕期是罕见的。
  • 其他治疗方法,如心理治疗和运动,已被证明有效,应优先于药物治疗。

主要结论 (讨论)

  • SSRIs是致畸的(会引起出生缺陷),因为它们在胚胎发育过程中干扰了5-羟色胺信号、生物电信号和钙信号。
  • SSRIs引起的缺陷遵循一致的模式,易于将其与药物的作用机制联系起来。
  • 怀孕期间使用SSRIs的益处小于其风险,应优先考虑其他治疗方法。
  • 需要更多的研究来全面了解SSRIs对胚胎发育的影响。

SSRIs与怀孕:风险与益处

  • 对于大多数怀孕的女性,SSRIs的风险大于其好处,尤其是对于轻度至中度抑郁的孕妇。
  • 治疗抑郁症的非药物治疗方法,如心理治疗和生活方式改变,应是孕期的首选治疗。
  • 只有在绝对必要时才应使用SSRIs,在使用之前应仔细考虑对胎儿的风险。